Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Fleischmann

Showing results (71-80 of 160) with videos related to

Pageof 16
Sort By:
The Journal of Membrane Biology|June 30, 1980
Alamethicin-induced conductances in lipid bilayers: I. Data analysis and simple steady-state modelM Fleischmann, C Gabrielli, M T Labram, et al.
Chemical Communications (Cambridge, England)|July 23, 2016
Facile synthesis of one-dimensional organometallic-organic hybrid polymers based on a diphosphorus complex and flexible bipyridyl linkersM Elsayed Moussa, B Attenberger, E V Peresypkina, et al.
Clinical Rheumatology|July 10, 2014
Efficacy of golimumab plus methotrexate in methotrexate-naïve patients with severe active rheumatoid arthritisPaul Emery, Roy M Fleischmann, Elizabeth C Hsia, et al.
Annales De Dermatologie Et De Venereologie|January 1, 1992
[Cutaneous Cytomegalovirus ulceration in AIDS: diagnosis by in situ hybridization and response to treatment]M Fleischmann, B Milpied, B Dréno, et al.
The British Journal of Dermatology|April 1, 1992
Induction of myelo-monocytic My7 antigen (CD13) expression by interferon-alpha in basal cells of cutaneous T-cell lymphomasB Dreno, M Fleischmann, S Valard, et al.
Archives of Dermatology|September 1, 1993
In vitro induction of basal keratinocyte MY7 antigen expression in cutaneous T-cell lymphoma is associated with response to interferon-alfa therapyP Celerier, M Fleischmann, N Basset-Seguin, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 12, 2014
A randomized, double-blind, placebo-controlled, twelve-week, dose-ranging study of decernotinib, an oral selective JAK-3 inhibitor, as monotherapy in patients with active rheumatoid arthritisRoy M Fleischmann, Nemanja S Damjanov, Alan J Kivitz, et al.
Journal of Biological Response Modifiers|August 1, 1984
Discrimination between nonmalignant and malignant cells by combinations of IFN-gamma and IFN-alpha/betaW R Fleischmann, R C Newton, C M Fleischmann, et al.
The Journal of Rheumatology|August 16, 2015
Longterm Safety of Rituximab: Final Report of the Rheumatoid Arthritis Global Clinical Trial Program over 11 YearsRonald F van Vollenhoven, Roy M Fleischmann, Daniel E Furst, et al.
RMD Open|March 4, 2017
DAS28-CRP and DAS28-ESR cut-offs for high disease activity in rheumatoid arthritis are not interchangeableRoy M Fleischmann, Désirée van der Heijde, Philip V Gardiner, et al.
Pageof 16

Showing results (71-80 of 160) with videos related to

Sort By:
Pageof 16
The Journal of Membrane Biology|June 30, 1980
Alamethicin-induced conductances in lipid bilayers: I. Data analysis and simple steady-state modelM Fleischmann, C Gabrielli, M T Labram, et al.
Chemical Communications (Cambridge, England)|July 23, 2016
Facile synthesis of one-dimensional organometallic-organic hybrid polymers based on a diphosphorus complex and flexible bipyridyl linkersM Elsayed Moussa, B Attenberger, E V Peresypkina, et al.
Clinical Rheumatology|July 10, 2014
Efficacy of golimumab plus methotrexate in methotrexate-naïve patients with severe active rheumatoid arthritisPaul Emery, Roy M Fleischmann, Elizabeth C Hsia, et al.
Annales De Dermatologie Et De Venereologie|January 1, 1992
[Cutaneous Cytomegalovirus ulceration in AIDS: diagnosis by in situ hybridization and response to treatment]M Fleischmann, B Milpied, B Dréno, et al.
The British Journal of Dermatology|April 1, 1992
Induction of myelo-monocytic My7 antigen (CD13) expression by interferon-alpha in basal cells of cutaneous T-cell lymphomasB Dreno, M Fleischmann, S Valard, et al.
Archives of Dermatology|September 1, 1993
In vitro induction of basal keratinocyte MY7 antigen expression in cutaneous T-cell lymphoma is associated with response to interferon-alfa therapyP Celerier, M Fleischmann, N Basset-Seguin, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 12, 2014
A randomized, double-blind, placebo-controlled, twelve-week, dose-ranging study of decernotinib, an oral selective JAK-3 inhibitor, as monotherapy in patients with active rheumatoid arthritisRoy M Fleischmann, Nemanja S Damjanov, Alan J Kivitz, et al.
Journal of Biological Response Modifiers|August 1, 1984
Discrimination between nonmalignant and malignant cells by combinations of IFN-gamma and IFN-alpha/betaW R Fleischmann, R C Newton, C M Fleischmann, et al.
The Journal of Rheumatology|August 16, 2015
Longterm Safety of Rituximab: Final Report of the Rheumatoid Arthritis Global Clinical Trial Program over 11 YearsRonald F van Vollenhoven, Roy M Fleischmann, Daniel E Furst, et al.
RMD Open|March 4, 2017
DAS28-CRP and DAS28-ESR cut-offs for high disease activity in rheumatoid arthritis are not interchangeableRoy M Fleischmann, Désirée van der Heijde, Philip V Gardiner, et al.
Pageof 16